Lymphoma Clonal Growth & Chemotherapy Response: Understanding Cancer Dynamics

What Lymphoma Clonal Growth Is

Lymphoma is a type of cancer that originates in the lymphatic system, particularly affecting B-cells. The clonal growth refers to the uncontrolled proliferation of these malignant cells within a lymph node or other affected areas. This growth can be modeled using mathematical principles such as Gompertzian kinetics, which describe how tumor size changes over time with limited resources and competition among cells.

The simulation uses this model to represent the expansion of a single clone of B-cells in a 2D packed cell cluster, allowing users to observe the dynamics of clonal growth under various conditions.

Why It Happens

Lymphoma occurs when B-cells undergo genetic mutations that cause them to proliferate uncontrollably. These cells can form a dense cluster within lymph nodes, competing for nutrients and space. The Gompertzian model captures this competition by assuming that growth slows as the tumor approaches its carrying capacity due to limited resources.

Understanding these dynamics is crucial for developing effective treatment strategies. Chemotherapy aims to kill cancer cells while minimizing harm to healthy tissues. By simulating chemotherapy cycles, users can observe how different treatments impact the clonal population and potentially lead to remission or relapse.

Chemotherapy Response Mechanisms

Chemotherapy works by targeting rapidly dividing cells, which includes both cancerous and normal cells. The log-kill hypothesis suggests that a fixed fraction of the tumor is killed with each treatment cycle, leading to exponential decay in tumor size over time if all other factors remain constant.

In the simulation, users can adjust parameters such as chemotherapy cycle interval and log-kill fraction per cycle to see how these affect the clonal population. This helps illustrate the balance between effective treatment and potential side effects.

Impact of Immune Surveillance

The immune system plays a critical role in monitoring and eliminating cancer cells. In the simulation, users can adjust the strength of background immune surveillance to observe how it influences tumor growth and response to chemotherapy. Enhanced immune function can help reduce tumor size more effectively but may also lead to increased side effects.

Understanding these interactions is essential for developing personalized treatment plans that optimize both therapeutic efficacy and patient safety.

Frequently asked questions

Try it live

Everything above runs in your browser — open Lymphoma Clonal Growth & Chemotherapy Response (2D) and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.